<< . .

. 13
( : 555)



. . >>

, Glenmark Laboratories
-,
, LOK-BETA Pharmaceuticals
OJ04A D01 , Cadila
, Ameda Pharma
200, Tad Pharma
, Genom Biotech;
, Maty
400, Tad Pharma
LOK-BETA Pharmaceuticals; Lupin
, Himanshu Overseas
800, Tad Pharma
, Macleods Pharmaceuticals Ltd;
, Norton
™, Glaxo Wellcome Operations;

, Genom Biotech
GlaxoSmithKline Pharmaceuticals
OJ04A D03
®, Janssen
, Medochemie
, Lupin
,
, PRO. MED. CS Praha
, Genom Biotech;
OJ02A C03 OJ05A B04
LOK-BETA Pharmaceuticals; ;
,PfizerInc.
,Valeant

, Macleods Pharmaceuticals Ltd -,
J02A X
J04A K , Pharmascience
, Roche

OJ02A X01 ®, Schering-Plough Central East
OJ04A K01 , Lupin
,Valeant
, Medico
, Macleods Pharmaceuticals Ltd;
OJ02A X04 , Roche
, Lupin
,
-, Marion Biotec
®, Merck Sharp & Dohme Idea
,
, Eupharm; Genom Biotech; KRKA;
OJ02A X10** , Lemery
Umedica; ; ;
, Walsh Pharma
OJ05A B06
, Guna
-, , Roche; Roche Products
--, Heel
-,
OJ05A B09
J04 , 500, Ajanta
, Novartis Pharma
OJ04A K02
OJ05A B11
, Macleods Pharmaceuticals Ltd
™,GlaxoSmithKline
J04A , Lupin
,
400, Ajanta
OJ05A B15*
, Marion Biotec
, ; ; ®, Berlin-Chemie AG (Menarini Group)
J04A A ;
J05A C
-,
OJ05A C02
,
OJ04A A02 400, Umedica ,
,-
J04A M , ; ;
-, ,

, Planline -,
, VVS Pharmaceuticals and Chemicals OJ04A M02 -,
,
J05A E
,
,
OJ04A M05 ,
OJ05A E01
J04A B
, R.P. Scherer
OJ04A B01 , Elegant India
OJ05A E02
, Macleods Pharmaceuticals Ltd OJ04A M06 , , , Ranbaxy
, LOK-BETA Pharmaceuticals;
-400, Hetero Drugs

-, Mili Healthcare ®, Merck Sharp & Dohme
OJ04A B02 -, Mili Healthcare OJ05A E03
, -4, Rusan Pharma , Abbott Lab.
, Marion Biotec , Macleods Pharmaceuticals Ltd;
OJ05A E04
, Macleods Pharmaceuticals Ltd;
J04B , Roche
-, Lupin
, Cipla
, Elegant India; Genom Biotech;
-250, Hetero Drugs
; ; ;
J04B A
, Gycross




2005 -29

OJ05A E08* OJ06A A02 OJ06B B20**
, BMS ߠ
OJ05A E20* ߠߠ I
, Abbott Lab. ߠ, TORCH-
J05A F :
,
,
OJ06A A04
1 ,

OJ05A F01 OJ06B B21**
A, B, C, E, F
,
,

OJ06A A05 ,
-Z, Ranbaxy
II
- 300, Hetero Drugs

, Cadila Healthcare
2 ,
, Cipla

OJ06B B22*
™,
,
GlaxoSmithKline; GlaxoSmithKline Export
Toxoplasma Gondii
OJ06A A10**
OJ05A F02 TORCH-
.
, BMS : ,
,
, Ranbaxy
J06B
, Cipla
100, Hetero Drugs TOXOPLASMA GONDII,
J06B A
OJ05A F04 OJ06B B30

, Ranbaxy -,
OJ06B A02
, BMS
J07
, Cipla

, Gycross
J07A

30, Hetero Drugs
͠
40, Hetero Drugs
J07A F
OJ05A F05 ,
OJ07A F01
͠
™,GlaxoSmithKline
ɠߠΠ --͠
, Ranbaxy
-150, Hetero Drugs ,
, Cadila Healthcare
, Cipla
,
™, Glaxo Wellcome Operations; ,
GlaxoSmithKline Export J07A G Hemophilus
OJ05A F06 ,
influenzae B
,
, Ranbaxy
OJ07A G01 Hemophilus influenzae B,
OJ05A F30

, Genom Biotech
,
, Ranbaxy -
ZLB Bioplasme
-30, Ranbaxy ,
5%
-40, Ranbaxy Haemophilus influaenzae B, Aventis Pasteur
,
, Cipla
OJ07A G51
Instituto Grifols
, Hetero Drugs
J06B B Hemophilus influenzae B,
™, GlaxoSmithKline Export

™, Glaxo Wellcome Operations
, Cipla ™ ,
OJ06B B01 -D (rh)
J05A G Haemophilus
Rho
influenzae b, GlaxoSmithKline
(D),
J07A H
OJ06B B04
OJ05A G01
OJ07A H03
® , Boehringer Ingelheim

, Hetero Drugs
B,
, Cipla

OJ06B B05
, Ranbaxy
+
, Gycross
, Aventis Pasteur
OJ05A G03 ͠ɠǠ J07A L
®, Merck Sharp & Dohme Idea
ȠȠȠ,
, Gycross OJ07A L01

200, Hetero Drugs

OJ06B B08
600, Hetero Drugs
23
, Cipla , Aventis Pasteur
, Ranbaxy
J07A M
J05A H ,
OJ06B B09 OJ07A M01
OJ05A H01

, Glaxo Wellcome Production
,
OJ05A H02
,

, Roche
TORCH-
J05A X -
: ,
, Serum Institute

-
OJ06B B10
OJ05A X05 ,
.
, ®
-

, ,
«»....
, TEVA
OJ06B B17** OJ07A M51
OJ05A X10**

--, Heel
-

,
,
, Heel - -
OJ06B B18**
J06

, ,

-- -
,
J06A
OJ06B B19**


J06A A
,
TORCH-
OJ06A A01 -- -
: —,


,
,
— ,

2005
-30

J07B K
-- - ™-
, GlaxoSmithKline
OJ07B K01
, -

. , LG Life Sciences
OJ07B C02 ™

,GlaxoSmithKline
(-), Serum Institute

..
J07B L
, Aventis Pasteur


™-1440, GlaxoSmithKline
, Aventis Pasteur
™-720 , GlaxoSmithKline
J07A P OJ07B L01
OJ07B C20

OJ07A P03 ™,GlaxoSmithKline
,
™ߠ,GlaxoSmithKline
.
™ ,
J07B D J07B X
GlaxoSmithKline

OJ07B D01
, Aventis Pasteur , -

J07A X

,
- --
J07C
,
, ,
™ ,


GlaxoSmithKline
-,Lek


-ˠ,Lek , Aventis Pasteur

, OJ07B D52 , ,
, , ( ),

( )
, , (DTPa),

GlaxoSmithKline b, Aventis Pasteur
, ,
-- J07C A
GlaxoSmithKline
, . / MMR II/ R.O.R.

,
, OJ07C A02 --
, Aventis Pasteur

J07B E -
,

..
, ,
, , Aventis Pasteur OJ07B E01 ( ) ,
, Pierre Fabre
GlaxoSmithKline
J07B
, ,

J07B A
, , Aventis Pasteur
OJ07B A01
, Aventis Pasteur , ,
J07B F ( )

( ), Aventis Pasteur

® , Chiron Behring
OJ07C A05 - -
® , Chiron Behring
OJ07B F02
J07B B -

OJ07B B01 , , (
) , GlaxoSmithKline
® ™
1, 2,
,SolvayPharmaceuticals , ,
3 , .
, GlaxoSmithKline

, Aventis Pasteur OJ07C A09 -Haemophilus

, Berna Biothech (, ,
influenzae B---
™ , ), GlaxoSmithKline
-
GlaxoSmithKline
OJ07B B02 , ™
Aventis Pasteur ,

J07B G , (

- , OJ07B G01 ), B,

,

<< . .

. 13
( : 555)



. . >>